Abstract:Neurological diseases are one of the most pressing issues in modern times worldwide. It thus possesses explicit attention from researchers and medical health providers to guard public health against such an expanding threat. Various treatment modalities have been developed in a remarkably short time but, unfortunately, have yet to lead to the wished-for efficacy or the sought-after clinical improvement. The main hurdle in delivering therapeutics to the brain has always been the blood-brain barrier which still represents an elusive area with lots of mysteries yet to be solved. Meanwhile, nanotechnology has emerged as an optimistic platform that is potentially holding the answer to many of our questions on how to deliver drugs and treat CNS disorders using novel technologies rather than the unsatisfying conventional old methods. Nanocarriers can be engineered in a way that is capable of delivering a certain therapeutic cargo to a specific target tissue. Adding to this mind-blowing nanotechnology, the revolutionizing gene-altering biologics can have the best of both worlds, and pave the way for the long-awaited cure to many diseases, among those diseases thus far are Alzheimer's disease (AD), brain tumors (glioma and glioblastoma), Down syndrome, stroke, and even cases with HIV. The review herein collects the studies that tested the mixture of both sciences, nanotechnology, and epigenetics, in the context of brain therapeutics using three main categories of gene-altering molecules (siRNA, miRNA, and CRISPR) with a special focus on the advancements regarding the new favorite, intranasal route of administration.

Strategies and materials of "SMART" non-viral vectors: Overcoming the barriers for brain gene therapy

Non-viral gene delivery and therapeutics targeting to brain

Progress on brain-targeting non-viral gene delivery systems

Current Advances in Vehicles for Brain Gene Delivery

Nucleic acid drug vectors for diagnosis and treatment of brain diseases

Non‐viral Nucleic Acid Delivery to the Central Nervous System and Brain Tumors

Nature-inspired dynamic gene-loaded nanoassemblies for the treatment of brain diseases

Viral vectors for gene delivery to the central nervous system

Present Insights into the progress in gene therapy delivery systems for central nervous system diseases

Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies

Gene therapy for CNS disorders: modalities, delivery and translational challenges

Emerging non-viral vectors for gene delivery

Emerging trends in virus and virus-like particle gene therapy delivery to the brain

The Trojan Horse Liposome Technology for Nonviral Gene Transfer across the Blood-Brain Barrier

Development of Foamy Virus Vectors for Gene Therapy for Neurological Disorders and Other Diseases

Non-viral Vectors in Gene Therapy: Recent Development, Challenges, and Prospects

Rational Design of Sirna-Based Delivery Systems for Effective Treatment of Brain Diseases

Strategies for enhanced gene delivery to the central nervous system

Viral vectors for therapy of neurologic diseases

Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration

BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment